CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −660 | $400.00 | $264K | 455 |
| 2026-11-05 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −455 | $402.00 | $183K | 0 |
| 2026-09-30 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −1,115 | $375.00 | $418K | 0 |
| 2026-08-11 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +812 | $194.47 | $158K | 812 |
| 2026-08-11 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +1,058 | $213.32 | $226K | 1,870 |
| 2026-08-11 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +796 | $159.03 | $127K | 2,666 |
| 2026-08-11 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −2,666 | $360.00 | $960K | 0 |
| 2026-08-11 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −10,556 | 0 | ||
| 2026-08-11 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −13,754 | 57,369 | ||
| 2026-08-11 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −10,348 | 88,582 | ||
| 2026-07-30 | Lee Chan Henry SVP, General Counsel | Sale | −1,044 | $323.69 | $338K | 0 |
| 2026-07-22 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +514 | $194.47 | $100K | 514 |
| 2026-07-22 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +665 | $213.32 | $142K | 1,179 |
| 2026-07-22 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +490 | $159.03 | $78K | 1,669 |
| 2026-07-22 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −1,669 | $325.00 | $542K | 0 |
| 2026-07-22 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −6,682 | 10,556 | ||
| 2026-07-22 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −8,645 | 71,123 | ||
| 2026-07-22 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −6,370 | 98,930 | ||
| 2026-07-08 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +202 | $194.47 | $39K | 202 |
| 2026-07-08 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +266 | $213.32 | $57K | 468 |
Page 1 of 7 · 140 trades